Royal Bank of Canada
CDMO

Royal Bank of Canada’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Royal Bank of Canada’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,506,731
Closed -$31M – 7391
2024
Q4 		$31M Sell
2,506,731
-321,097
-11% -$3.68M 0.01% 1081
2024
Q3 		$32.2M Sell
2,827,828
-41,098
-1% -$412K 0.01% 1053
2024
Q2 		$20.5M Buy
2,868,926
+240,418
+9% +$1.84M ﹤0.01% 1233
2024
Q1 		$17.6M Buy
2,628,508
+147,293
+6% +$1.01M ﹤0.01% 1332
2023
Q4 		$16.1M Buy
2,481,215
+350,465
+16% +$2.26M ﹤0.01% 1412
2023
Q3 		$20.1M Buy
2,130,750
+10,750
+0.5% +$129K 0.01% 1154
2023
Q2 		$29.6M Buy
2,120,000
+473,731
+29% +$8.08M 0.01% 962
2023
Q1 		$30.9M Sell
1,646,269
-98,508
-6% -$1.62M 0.01% 893
2022
Q4 		$24M Buy
1,744,777
+618,454
+55% +$9.47M 0.01% 1045
2022
Q3 		$21.5M Buy
1,126,323
+683,470
+154% +$12.5M 0.01% 1027
2022
Q2 		$6.76M Buy
442,853
+61,155
+16% +$905K ﹤0.01% 1877
2022
Q1 		$7.78M Buy
381,698
+117,032
+44% +$2.38M ﹤0.01% 1902
2021
Q4 		$7.72M Sell
264,666
-16,500
-6% -$472K ﹤0.01% 2072
2021
Q3 		$6.06M Buy
281,166
+1,773
+0.6% +$42.8K ﹤0.01% 2173
2021
Q2 		$7.17M Buy
279,393
+273,453
+4,604% +$5.84M ﹤0.01% 2057
2021
Q1 		$108K Buy
5,940
+2,319
+64% +$38.5K ﹤0.01% 5410
2020
Q4 		$42K Buy
3,621
+2,028
+127% +$18.5K ﹤0.01% 5739
2020
Q3 		$11K Sell
1,593
-54
-3% -$409 ﹤0.01% 5900
2020
Q2 		$12K Sell
1,647
-162
-9% -$904 ﹤0.01% 5779
2020
Q1 		$10K Sell
1,809
-3,412
-65% -$20.6K ﹤0.01% 5839
2019
Q4 		$39K Buy
5,221
+4,342
+494% +$25.3K ﹤0.01% 5561
2019
Q3 		$5K Hold
879
– – ﹤0.01% 6057
2019
Q2 		$5K Buy
879
+565
+180% +$2.33K ﹤0.01% 6341
2019
Q1 		$1K Sell
314
-572
-65% -$2.33K ﹤0.01% 6695
2018
Q4 		$4K Sell
886
-1,407
-61% -$7.34K ﹤0.01% 6265
2018
Q3 		$16K Buy
2,293
+977
+74% +$5.79K ﹤0.01% 5794
2018
Q2 		$5K Hold
1,316
– – ﹤0.01% 6056
2018
Q1 		$4K Hold
1,316
– – ﹤0.01% 6005
2017
Q4 		$5K Buy
1,316
+430
+49% +$1.84K ﹤0.01% 6081
2017
Q3 		$3K Sell
886
-43
-5% -$161 ﹤0.01% 6526
2017
Q2 		$4K Buy
929
+300
+48% +$1.23K ﹤0.01% 6137
2017
Q1 		$3K Sell
629
-197
-24% -$660 ﹤0.01% 6368
2016
Q4 		$1K Buy
826
+169
+26% +$395 ﹤0.01% 6573
2016
Q3 		$2K Hold
657
– – ﹤0.01% 6208
2016
Q2 		$2K Sell
657
-588
-47% -$1.64K ﹤0.01% 6170
2016
Q1 		$4K Sell
1,245
-7
-0.6% -$37 ﹤0.01% 5987
2015
Q4 		$10K Sell
1,252
-17,962
-93% -$145K ﹤0.01% 5974
2015
Q3 		$137K Sell
19,214
-35,074
-65% -$293K ﹤0.01% 4577
2015
Q2 		$497K Buy
54,288
+1,595
+3% +$15.3K ﹤0.01% 3595
2015
Q1 		$498K Buy
52,693
+52,057
+8,185% +$501K ﹤0.01% 3512
2014
Q4 		$6K Hold
636
– – ﹤0.01% 5759
2014
Q3 		$6K Hold
636
– – ﹤0.01% 5615
2014
Q2 		$8K Hold
636
– – ﹤0.01% 5467
2014
Q1 		$8K Hold
636
– – ﹤0.01% 5489
2013
Q4 		$6K Sell
636
-41
-6% -$386 ﹤0.01% 5575
2013
Q3 		$6K Buy
677
+41
+6% +$407 ﹤0.01% 5592
2013
Q2 		$5K Buy
+636
New +$6.67K ﹤0.01% 5458

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's CDMO Position: Q1 2025 in Review

Royal Bank of Canada sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 2,506,731 shares — an estimated $31M sold.

Royal Bank of Canada first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $32.2M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Royal Bank of Canada reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 2,506,731 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $31M.
  • Royal Bank of Canada first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
  • Royal Bank of Canada's Avid Bioservices, Inc. Common Stock position peaked at $32.2M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.